GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenicin Inc (OTCPK:RGIN) » Definitions » Price-to-Operating-Cash-Flow

Regenicin (Regenicin) Price-to-Operating-Cash-Flow : (As of May. 24, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Regenicin Price-to-Operating-Cash-Flow?

As of today (2024-05-24), Regenicin's share price is $0.0001. Regenicin's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2023 was $-0.00. Hence, Regenicin's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Regenicin's Price-to-Operating-Cash-Flow or its related term are showing as below:

RGIN's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 26.455
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Regenicin's Cash Flow from Operations per share for the three months ended in Mar. 2023 was $-0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2023 was $-0.00.


Regenicin Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Regenicin's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regenicin Price-to-Operating-Cash-Flow Chart

Regenicin Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Regenicin Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Regenicin's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Regenicin's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regenicin's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regenicin's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Regenicin's Price-to-Operating-Cash-Flow falls into.



Regenicin Price-to-Operating-Cash-Flow Calculation

Regenicin's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.0001/-0.004
=

Regenicin's Share Price of today is $0.0001.
Regenicin's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Regenicin Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Regenicin's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Regenicin (Regenicin) Business Description

Industry
Traded in Other Exchanges
N/A
Address
10 High Court, Little Falls, NJ, USA, 07424
Regenicin Inc is a biotechnology company specializing in the development of regenerative cell therapies to restore the health of damaged tissues and organs. Its skin substitute product candidate comprises of NovaDerm. NovaDerm is a multi-layered tissue-engineered living skin prepared by utilizing autologous (patient's own) skin cells. It is a graftable cultured epithelium skin substitute containing both epidermal and dermal components with a collagen base. The technology has been clinically tested in Hundreds of pediatric, catastrophic burn patients.

Regenicin (Regenicin) Headlines

No Headlines